Literature DB >> 16957935

Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate-associated osteonecrosis--a paradoxical observation?

Torsten Hansen1, C James Kirkpatrick, Christian Walter, Martin Kunkel.   

Abstract

Erosion of the bone is a common problem in patients suffering from infected osteoradionecrosis (IORN) or bisphosphonate-associated osteonecrosis (BON). Besides inflammatory mechanisms and infectious agents, osteoclasts were recently suggested to be specifically involved in the osteolytic mechanisms. We therefore investigated the immunohistochemical labeling of the cysteine proteinase cathepsin K, which plays a central role in osteoclast-mediated bone resorption, in tissue specimens of patients with BON (n=9; four male, five female; mean age=69.2 years) and IORN (n=10; nine male, one female; mean age=60.5 years), and compared the results with control specimens (n=8; six male, two female; mean age=60 years). In all cases, osteoclasts were the predominant cell type expressing cathepsin K. For semiquantitative analysis, we therefore defined osteoclasts as multinuclear giant cells attached to the bone and expressing cathepsin K. Significantly higher numbers of osteoclasts were found for both types of osteonecrosis when compared with the control group (BON+IORN vs controls: P=0.0000036). Within the pathological lesions, IORN cases exhibited significantly less osteoclasts than BON (P=0.00097). Our study verified increased numbers of osteoclasts in patients suffering from BON and IORN. Although it is known that bisphosphonates (and to a lesser extent, irradiation, too) decrease osteoclast function, these findings suggest a critical involvement of osteoclasts in the mechanisms of bone destruction in the respective lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16957935     DOI: 10.1007/s00428-006-0261-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

Review 1.  Cell biology of the osteoclast.

Authors:  G D Roodman
Journal:  Exp Hematol       Date:  1999-08       Impact factor: 3.084

2.  Comparison in localization between cystatin C and cathepsin K in osteoclasts and other cells in mouse tibia epiphysis by immunolight and immunoelectron microscopy.

Authors:  T Yamaza; Y Tsuji; T Goto; M A Kido; K Nishijima; R Moroi; A Akamine; T Tanaka
Journal:  Bone       Date:  2001-07       Impact factor: 4.398

Review 3.  Dental complications of head and neck radiotherapy: Part 1.

Authors:  N Andrews; C Griffiths
Journal:  Aust Dent J       Date:  2001-06       Impact factor: 2.291

4.  Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma.

Authors:  T Hansen; R E Unger; A Gaumann; I Hundorf; J Maurer; C J Kirkpatrick; J Kriegsmann
Journal:  Mod Pathol       Date:  2001-12       Impact factor: 7.842

5.  Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase.

Authors:  Keith Thompson; James E Dunford; Frank H Ebetino; Michael J Rogers
Journal:  Biochem Biophys Res Commun       Date:  2002-01-18       Impact factor: 3.575

6.  Septic osteoradionecrosis of the mandible associated with pathological fracture: report of two cases.

Authors:  D T Millett; I L Chapple; P N Hirschmann; A M Corrigan
Journal:  Clin Radiol       Date:  1990-06       Impact factor: 2.350

7.  Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.

Authors:  Torsten Hansen; Martin Kunkel; Achim Weber; C James Kirkpatrick
Journal:  J Oral Pathol Med       Date:  2006-03       Impact factor: 4.253

Review 8.  [Bisphosphonate-associated osteonecrosis of the jaw].

Authors:  M H Abu-Id; Y Açil; J Gottschalk; T Kreusch
Journal:  Mund Kiefer Gesichtschir       Date:  2006-03

9.  Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects.

Authors:  G Støre; M Boysen
Journal:  Clin Otolaryngol Allied Sci       Date:  2000-10

10.  Light and electron microscopic observations of osteoclastic alveolar bone resorption in rats monoinfected with Actinomyces naeslundii.

Authors:  P R Garant
Journal:  J Periodontol       Date:  1976-12       Impact factor: 6.993

View more
  9 in total

1.  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Satoru Toyosawa; Toshihiko Nagata; Masahiro Urade
Journal:  J Bone Miner Metab       Date:  2010-03-24       Impact factor: 2.626

2.  Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.

Authors:  Felix Peter Koch; Christina Merkel; Thomas Ziebart; Ralf Smeets; Christian Walter; Bilal Al-Nawas
Journal:  Clin Oral Investig       Date:  2010-10-12       Impact factor: 3.573

3.  Actinomycosis of the jaws--histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis.

Authors:  Torsten Hansen; Martin Kunkel; Erik Springer; Christian Walter; Achim Weber; Ekkehard Siegel; C James Kirkpatrick
Journal:  Virchows Arch       Date:  2007-10-20       Impact factor: 4.064

4.  Hemangioma of the mandible: case report with special emphasis on bone degradation.

Authors:  Torsten Hansen; Martin Kunkel; Detlef Katenkamp; Sami Eletr; Wilfried Wagner
Journal:  Oral Maxillofac Surg       Date:  2009-12

5.  Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study.

Authors:  Gelsomina L Borromeo; Caroline Brand; John G Clement; Michael McCullough; Wendy Thomson; Elly Flitzanis; John D Wark
Journal:  BMC Musculoskelet Disord       Date:  2011-04-10       Impact factor: 2.362

Review 6.  Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons.

Authors:  Kyoung Min Kim; Yumie Rhee; Yong-Dae Kwon; Tae-Geon Kwon; Jeong Keun Lee; Deog-Yoon Kim
Journal:  J Bone Metab       Date:  2015-11-30

7.  Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.

Authors:  Christian Gross; Manuel Weber; Kay Creutzburg; Patrick Möbius; Raimund Preidl; Kerstin Amann; Falk Wehrhan
Journal:  J Transl Med       Date:  2017-06-06       Impact factor: 5.531

8.  Osteonecrosis of the Jaw Beyond Bisphosphonates: Are There Any Unknown Local Risk Factors?

Authors:  Johann Lechner; Volker von Baehr; Bernd Zimmermann
Journal:  Clin Cosmet Investig Dent       Date:  2021-01-19

9.  Effect of Human Umbilical Cord Matrix-Derived Mesenchymal Stem Cells on Bisphosphonate-Related Osteonecrosis of the Jaw.

Authors:  Gwanghyun Yang; Young-Nam Kim; Hyunjeong Kim; Bu-Kyu Lee
Journal:  Tissue Eng Regen Med       Date:  2021-08-04       Impact factor: 4.451

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.